Ignite Creation Date:
2025-12-24 @ 3:53 PM
Ignite Modification Date:
2026-01-28 @ 6:59 AM
Study NCT ID:
NCT00504192
Status:
COMPLETED
Last Update Posted:
2014-05-20
First Post:
2007-07-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer
Sponsor:
Soonchunhyang University Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SCH-GO-BTC1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dae Sik Hong
Old Organization:
Soonchunhyang Bucheon Hospital